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Translation
Gholson	J.	Lyon,	M.D.	Ph.D.
“There	are	~12	billion	nucleotides	in	every	cell	of	the	human	body,	and	there	are	
~25-100	trillion	cells	in	each	human	body.	Given	somatic	mosaicism,	epigenetic	
changes	and	environmental	differences,	no	two	human	beings	are	the	same,	
particularly	as	there	are	only	~7	billion	people	on	the	planet”.	





Nuclear	pores	in	a	yeast	nucleus

Trimastix pyriformis is	a	quadriflagellate,	free-living,	bacterivorous
heterotrophic	nanoflagellate from	anoxic	freshwaters	that	lacks	mitochondria
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The translational apparatus is one of the major targets for antibiotics in the bacterial cell. Antibiotics predominantly interact with the functional centers of the ribosome, namely 
the messenger RNA (mRNA)-transfer RNA (tRNA) decoding region on the 30S subunit, the peptidyltransferase center on the 50S subunit, or the ribosomal exit tunnel through 
which the nascent polypeptide chain passes during translation. Protein synthesis can be divided into three phases: initiation, elongation, and termination/recycling.
1. Initiation
Translation initiation operates through a 30S initiation complex (30S-IC), consisting of the 30S, mRNA, initiator fMet-tRNA, and three initiation factors, IF1, IF2, and IF3. Sub-
sequently, the 30S-IC associates with the 50S, which releases the initiation factors (IFs) and leaves the initiator-tRNA at the peptidyl-tRNA-binding site (P site), base-paired to 
the start codon of the mRNA. The antibiotics edeine, GE81112, and kasugamycin interfere with 30S-IC assembly, whereas formation of a functional 70S-IC is blocked by the 
orthosomycins and pactamycins.
2. Elongation
The elongation phase involves the movement of tRNAs in a cyclic fashion through the three tRNA-binding sites (A→P→E) on the ribosome. The first step in the cycle involves 
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its dissociation from the ribosome, allowing aa-tRNA accommodation. Peptide-bond formation then proceeds, transferring the entire polypeptide chain from the P-tRNA to the 
aa-tRNA in the A site. The ribosome now has a peptidyl-tRNA at the A site and an uncharged tRNA at the P site. This ribosomal state is highly dynamic with the tRNAs oscil-
lating between classical (A and P sites) and hybrid states (A/P and P/E sites on 30S/50S). EF-G binds to the ribosome, which stabilizes the tRNAs in hybrid states, hydrolyzes 
GTP to GDP, and catalyzes the translocation reaction. Translocation shifts the peptidyl-tRNA from the A/P hybrid state to the P site and the deacylated tRNA from the P/E to the 
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the elongation phase. Most antibiotics binding to the 30S perturb either tRNA binding, decoding, or translocation, whereas antibiotics targeting the 50S inhibit peptide-bond 
formation, extension of the polypeptide chain, or stable binding of translation factors. In contrast, some antibiotics interact directly with elongation factors and prevent them 
from dissociating from the ribosome.
3. Termination/Recycling
Arrival of an mRNA stop codon in the A site of the ribosome signals the termination of protein synthesis. Release factor 1 (RF1) or RF2 binds to the ribosome and hydrolyzes 
the peptidyl-tRNA bond, releasing the translated polypeptide chain from the ribosome. RF1/2 is recycled from the ribosome by RF3 in a GTP-dependent fashion. The ribosome 
is then split into subunits by the concerted action of EF-G and ribosome recycling factor (RRF), thus recycling the components for the next round of translation. There are no 
antibiotics that specifically inhibit termination and ribosome recycling; however antibiotics that target EF-G, such as α-sarcin, fusidic acid, and thiopeptides, also inhibit ribo-
some recycling.
Abbreviations
30S, small ribosomal subunit; 50S, large ribosomal subunit; aa-tRNA, aminoacyl-tRNA; A site, aa-tRNA-binding site; E site, exit site for tRNA; EF, elongation factor; IF, initiation 
factor; mRNA, messenger RNA; P-tRNA, peptidyl-tRNA; P site, P-tRNA-binding site; PTC, peptidyltransferase center; RRF, ribosome recycling factor; RF, release factor; tRNA, 
transfer RNA.
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Aminoglycosides Apramycin, gentamycin, hygromycin B, 
kanamycin, neomycin, paromomycin, 
tobramycin
Elongation (translocation) Most aminoglycoside antibiotics induce translational misreading by promoting 
binding of near-cognate tRNAs, but the biological effect is probably due to inhibition 
of the translocation reaction and promotion of back-translocation.
Edeine Edeine A Initiation (fMet-tRNA 
binding) 
Edeine prevents binding of the initiator tRNA to the 30S subunit in an mRNA-
dependent manner.
GE81112 GE81112 Initiation (fMet-tRNA 
binding) 
GE81112 inhibits binding of the initiator tRNA to the 30S subunit in an mRNA-
independent manner.
Kasugamycin Kasugamycin Initiation (fMet-tRNA 
binding) 
Kasugamycin inhibits translation initiation of canonical mRNAs by binding in the 
path of the mRNA and preventing stable interaction of the initiator tRNA with the 
start codon. 
Pactamycin Pactamycin Initiation, elongation 
(translocation) 
Early data suggest that pactamycin allows 30S but not 70S initiation complex 
formation, whereas recently pactamycin was shown to inhibit translocation in a 
tRNA-mRNA-dependent manner.
Spectinomycin Spectinomycin Elongation (translocation) Spectinomycin binds to the neck of the small subunit and prevents the relative 
movement of the head and body that is needed for the completion of translocation. 
Streptomycin Streptomycin Elongation (misreading) Streptomycin increases affinity of tRNA for the A site, has a modest inhibitory effect 
on translocation, promotes back-translocation, and induces high-level translational 
misreading.
Tetracyclines/glycylcyclines Doxycycline, minocycline, tetracycline/
tigecycline
Elongation (tRNA delivery) Tetracyclines prevent stable binding of the EF-Tu-tRNA-GTP ternary complex to 
the ribosome and inhibit accommodation of A-tRNAs upon EF-Tu-dependent GTP 
hydrolysis.
Viomycin Capreomycin, viomycin Elongation (translocation) Viomycin locks tRNAs in a hybrid-site translocation intermediate state, preventing 
conversion by EF-G into a posttranslocation state.
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Blasticidins Blasticidin S Elongation 
(peptidyltransferase) 
Two molecules of Blasticidin S mimic the C74 and C75 of P-tRNA and in doing 
so inhibit peptide bond formation by preventing tRNA binding at the P site of the 
peptidyltransferase center (PTC).
Chloramphenicols Chloramphenicol Elongation 
(peptidyltransferase) 
Chloramphenicol binds at the A site of the PTC where it perturbs placement of A 
site tRNA and thus prevents peptide bond formation.
Hygromycin A Hygromycin A Elongation 
(peptidyltransferase) 
Hygromycin A overlaps in its binding site with chloramphenicol and inhibits peptide 
bond formation by inhibiting the placement of the A site tRNA at the PTC.
Ketolides Cethromycin (ABT-773), telithromycin Elongation (nascent chain 
egress)  
Ketolides are derivatives of macrolides where the ketone group replaces the C3 
sugar. Ketolides exhibit the same mechanism of action as macrolides by blocking 
the ribosomal tunnel and inducing peptidyl-tRNA drop-off.
Lincosamides Clindamycin, lincomycin Elongation 
(peptidyltransferase) 
Lincosamides span across both A and P sites of the PTC and inhibit binding of 
tRNA substrates at both these sites.
Macrolides Azithromycin, carbomycin A, 
clarithromycin, erythromycin, 
spiramycin, troleandomycin, tylosin
Elongation (nascent chain 
egress) 
Macrolides bind within the ribosomal tunnel and prevent elongation of the nascent 
polypeptide chain, which leads to peptidyl-tRNA drop-off. Some macrolides, such 
as carbomycin A and tylosin, also directly inhibit peptide bond formation.
Orthosomycins Avilamycin, evernimicin Initiation (70S-IC formation) Orthosomycins interact with the large subunit and prevent the joining of the 30S-IC 
with the large subunit to form the 70S-IC in an IF2-dependent manner.
Oxazolidinones Eperezolid, linezolid Elongation 
(peptidyltransferase) 
Linezolid binds at the PTC in a position overlapping the aminoacyl moiety of 
A-tRNA, preventing tRNA accommodation and peptide bond formation.
Puromycin Puromycin Elongation 
(peptidyltransferase) 
Puromycin is a structural analog of the 3′ end of a tRNA, which binds at the A site of 
the PTC and triggers premature release of the nascent polypeptide chain.
Ribotoxins α-sarcin Elongation (translocation), 
recycling 
α-sarcin cleaves the E. coli 23S rRNA on the 3′ side of G2661, abolishing the 
ribosome’s ability to stimulate the GTP hydrolysis activity of translation factors, 
such as EF-G.
Sparsomycin Sparsomycin Elongation 
(peptidyltransferase) 
Sparsomycin binds at the PTC where it blocks tRNA binding at the A site, while 
promoting translocation and stabilization of tRNA at the P site.
Streptogramins A/B Dalfopristin/quinupristin, virginiamycin 
M/S
Elongation 
(peptidyltransferase) 
Streptogramins A and B act synergistically to inhibit translation. SA compounds 
bind at the PTC overlapping A and P sites, whereas SB compounds bind within the 
tunnel in a similar location to macrolides.
Thiopeptides Micrococcin, nocathiacin, nosiheptide, 
thiazomycin, thiostrepton
Elongation (translocation), 
Recycling 
Thiopeptide antibiotics inhibit translocation by blocking the stable binding of EF-G 
to the ribosome. Thiopeptides also inhibit the action of translational GTPases, such 
IF2 and EF-Tu.
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Fusidic acid Fusidic acid Elongation (translocation) Fusidic acid stabilizes EF-G on the ribosome by allowing binding and GTP 
hydrolysis, but not Pi release, nor the associated conformational changes in EF-G 
necessary for dissociation.
GE2270A-like thiopeptides Amythiamicins, GE2270A, thiomuracins Elongation (tRNA delivery) The GE2270A-like thiopeptides, like pulvomycin, prevent ternary complex formation 
by binding to EF-Tu and blocking interaction of EF-Tu with aminoacyl-tRNAs. 
GE2270A and pulvomycin have distinct but overlapping binding sites on EF-Tu.
Kirromycins and enacyloxins Aurodox, kirromycin, and enacyloxin IIa Elongation (tRNA delivery) These drugs trap EF-Tu on the ribosome by allowing GTP hydrolysis but preventing 
Pi release and the conformational changes in EF-Tu that are necessary for tRNA 
release and EF-Tu dissociation.
Pulvomycin Pulvomycin Elongation (tRNA delivery) Pulvomycin prevents ternary complex formation by binding to EF-Tu and blocking 
interaction of EF-Tu with aminoacyl-tRNAs.
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SUMMARY
Cotranslational protein translocation is a universally
conserved process for secretory andmembrane pro-
tein biosynthesis. Nascent polypeptides emerging
from a translating ribosome are either transported
across or inserted into the membrane via the ribo-
some-bound Sec61 channel. Here, we report struc-
tures of a mammalian ribosome-Sec61 complex in
both idle and translating states, determined to 3.4
and 3.9 A˚ resolution. The data sets permit building
of a near-complete atomic model of the mammalian
ribosome, visualization of A/P and P/E hybrid-state
tRNAs, and analysis of a nascent polypeptide in
the exit tunnel. Unprecedented chemical detail is
observed for both the ribosome-Sec61 interaction
and the conformational state of Sec61 upon ribo-
some binding. Comparison of the maps from idle
and translating complexes suggests how conforma-
tional changes to the Sec61 channel could facilitate
translocation of a secreted polypeptide. The high-
resolution structure of the mammalian ribosome-
Sec61 complex provides a valuable reference for
future functional and structural studies.
INTRODUCTION
The maturation of nascent polypeptides relies on many factors
that dynamically associate with the translating ribosome. These
factors include modification enzymes, chaperones, targeting
complexes, and protein translocons. While many fundamental
aspects of protein translation are now understood in chemical
detail (Voorhees and Ramakrishnan, 2013), far less is known
about how these exogenous factors cooperate with the ribo-
some to facilitate nascent chain maturation.
Amajor classofproteins that relyextensivelyon ribosome-asso-
ciated machinery are secreted and integral membrane proteins
(Nyathi et al., 2013). In all organisms, a large proportion of these
proteins are cotranslationally translocated across or inserted into
the membrane. The exceptional prominence of this pathway in
mammals is underscored by the original discovery of ribosomes
as a characteristic feature of the endoplasmic reticulum mem-
brane (Palade, 1955). Thus, understanding the nature of mem-
brane-bound ribosomes and their role in secretory protein biosyn-
thesis has been a long-standing goal in cell biology.
After targeting to the membrane (Egea et al., 2005), ribosomes
synthesizing nascent secretory and membrane proteins dock
at a universally conserved protein conducting channel (PCC),
called the Sec61 complex in eukaryotes and the SecY complex
in prokaryotes and archaea (Park and Rapoport, 2012). The PCC
has two basic activities. First, it provides a conduit across
the membrane through which hydrophilic polypeptides can be
translocated. Second, it recognizes hydrophobic signal peptides
and transmembrane domains and releases them laterally into the
lipid bilayer.
These activities rely on binding partners that regulate PCC
conformation and provide the driving force for vectorial translo-
cation of the nascent polypeptide. The best characterized trans-
location partners are the ribosome and the prokaryote-specific
ATPase SecA. Extensive functional and structural studies of
the SecA-SecY posttranslational translocation system, in paral-
lel with the cotranslational ribosome-Sec61 system, have coa-
lesced into a general framework for protein translocation (Park
and Rapoport, 2012).
Over the past two decades several crystal structures and
cryo-EM reconstructions have led to numerous mechanistic
insights into these events. High-resolution crystal structures of
the large ribosomal subunit visualized the exit tunnel (Nissen
et al., 2000), whose conserved conduit was shown to align
with a bound Sec61 complex (Beckmann et al., 1997). While
structural analysis of the prokaryotic ribosome and translation
cycle progressed rapidly (Schmeing and Ramakrishnan, 2009),
the lower resolution of parallel PCC structures (Menetret et al.,
2000; Beckmann et al., 2001) posed a challenge to identifying
changes in its conformation at different stages of translocation.
A major advance was the crystal structure of the archaeal
SecYEb complex (Van den Berg et al., 2004), whichmade several
predictions about the nature and function of the translocation
channel that were supported by later studies. The ten transmem-
brane segments of SecY are arranged in a pseudosymmetric
orientationsuch that the twohalves (formedbyhelices1-5andhe-
lices 6-10) surround an hourglass-shaped pore occluded by the
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techniques (Scheres, 2010; Scheres, 2012b). Our initial data set
contained 80,019 ribosomal particles. In silico classification
of these particles (Figure S2) ag ees with several spects of its
biochemical characterization. First, nearly all ribosomes con-
tained a bound translocon, as classification of the final sample
could not isolate any translocon-free ribosomes. Second, while
the density for the area surrounding the translocon was hetero-
geneous due to a combination of accessory factors and the
detergent-lipid micelle, very high occupancy was observed for
the central Sec61 complex. Third, multiple classes of particles
could be sorted based on the conformation of the ribosome
and included translating and idle populations. The complete
data set and individual classes were separately analyzed to
extract their best features, which were incorporated into a com-
posite model for the complete 80S-Sec61 complex.
An initial reconstruction using the entire data set was calcu-
lated using a mask for the 60S subunit to avoid interference in
the angular assignment by the heterogeneous conformation of
the 40S. The resulting map, determined to 3.35 A˚ resolution,
was used to build the ribosomal RNA and proteins of the 60S
subunit. A distinctive class of !13% of particles contained two
tRNAs bound in the A/P and P/E hybrid state. These particles
were used to generate a 3.9 A˚ resolution map of the translating
ribosome-translocon complex, within which density for the
nascent polypeptide was observed throughout the ribosomal
tunnel. The remaining 69,464 particles lacking tRNA and a
nascent peptide were considered nontranslating ribosomes.
This class was processed using a 60Smask to build the idle ribo-
some-Sec61 map at 3.4 A˚ resolution. Finally, this idle class was
further subdivided by the degree of ribosomal ratcheting, and the
presence or absence of the translational GTPase eEF2. One of
these subclasses contained 36,667 particles and was used
to produce a 3.5 A˚ resolution map used for building of the 40S
ribosomal subunit and a well-ordered lateral stalk region. Thus,
by lever ging major advances in both image detection and
in silico analysis, a relatively small and heterogeneous data set
could be used to build a near-complete atomic model of the
mammalian 80S ribosome and high-resolution structures for
the Sec61 complex bound to the translating and idle ribosome
(see overview in Figure 1A). We will begin by presenting
the structure of the 80S ribosome, followed by discussion of
the Sec61 complex structure and its functional implications.
Throughout this study, we use the new unified nomenclature
for ribosomal proteins (see Table S1; Ban et al., 2014).
An Atomic Model of the Mammalian Ribosome
The porcine ribosome described in this study was determined
to an average resolution of 3.4 and 3.5 A˚ for the 60 and 40S,
respectively (Figure S3, Table S2), as judged by the ‘‘gold-stan-
dard’’ Fourier Shell Correlation (FSC = 0.143) criterion (Scheres
and Chen, 2012). Notably, much of the core of the 60S subunit
is at 3.0 A˚ resolution or better (Figure 1B), while the head of the
40S subunit, given its inherent flexibility, is at somewhat lower
resolution. The distal regions of several metazoan-specific
rRNA expansion segments, such as ES27L, protrude from the
ribosome and are presumably dynamic (Anger et al., 2013). As
in the earlier study, these regions of rRNA were not visualized
in our averaged maps. As the sample was prepared from an
actively translating tissue, there was no evidence for binding
of Stm1 or other sequestration factors that were observed in pre-
vious studies (Anger et al., 2013; Ben-Shem et al., 2011).
Using a recent model of the human ribosome generated at
!5.4 A˚ resolution as a starting point (Anger et al., 2013), we
have rebuilt each ribosomal protein and the rRNA, including
many amino acid side chains, RNA bases, and over 100 Mg2+
ions (Figure 2). Our density map allowed de novo building
of many regions that were previously approximated due to
lower resolution (Figure S4A). Additional eukaryote-specific
Figure 1. The Structure of a Mammalian Ribosome-Translocon Complex
(A) Model of the idle 80S ribosome in complex with Sec61, shown in red. The color scheme shown here is used throughout the manuscript: 40S rRNA is displayed
in orange, the 40S ribosomal proteins in brown, the 60S rRNA in cyan, and the 60S ribosomal proteins in dark blue. The region of the peptidyl transferase center
(PTC) is indicated.
(B) Cut view of the final unshar ned cryo-EM density map for both the i le 60S-Sec61 complex a d the 40S subunit, colored by local resolution in A˚ (Kucukelbir
et al., 2014). Also see Figure S3.
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Sec61a. The central pore was sufficiently large to house a model
of an extended polypeptide without clashes.
While the plug’s canonical position was not occupied in the
active state, we could not unambiguously assign it to an alternate
location. It is possible the plu adopts a variety of conform tions
in this sample (given the heterogen ous seq ences of transl -
cating nascent chains) or becomes disordered to allow translo-
cation. Given that the plug can be crosslinked to several dispa-
rate resid es within an active SecY, it is likely dynamic once
freed from its interactions with the pore ring. This flexibility may
be facilitated by the observed movements in helix 1. In the static
situation of a stalled nascent chain (G gala t al., 2014), the plug
may settle at its lowest energy state, perhaps explaining why it
was apparently seen near its original location. However steric
constraints would require at least a nominal shift in the plug to
accommodate the nascent peptide within the central pore.
Alth ugh f w r particles for the active S c61 complex led to a
lower-resolution map than that for the idle complex, some areas
are better resolved than others (Figures S6A and S6B). Helices 6-
9, along with loops 6/7 and 8/9, display the highest resolution
within the structure as judged by atomic B-factor (Figure S6C).
This provides confidence in c ncluding that this part of Sec61
has few if any substantive conformational changes relative to
the idle state. Thus, the C-terminal half of Sec61 effectively forms
a stable platform for ribosome interaction.
By contrast, the density for helices 2-4 is significantly weaker
than for either this same region in the idle Sec61 structure, or f r
helices 6-9 in the active structure (Figure S6). This observation
strongly argues that the position of helices 2-4 in the active
Sec61 is heterogeneous. Several nonmutually exclusive expla-
nations are possible: (i) heterogeneous clients at different stages
of transloction; (ii) different accessory proteins acting during
translocati n; nd (iii) inherent flexibility this region w n the
plug is displaced. Irrespective of the specific explanation (s), it
would seem clear that helices 6-9 provide a ribosome-stabilized
fulcrum, which allowsmovements within the remaining portion of
the molecule to accommodate the nascent chain.
Implications for Cotranslational Protein Translocation
The structures described here help refine our understanding
of several steps during cotranslational protein translocation
and provide mechanistic insights into the two stages for fully
activating the Sec61 channel (Figure 7). In the quiescent state
presumably represented by the isolated crystal structure (Van
den Berg et al., 2004), the channel is fully closed to both the
lumen and lipid bilayer. The first stage of activation involves
binding of the ribosome, which primes the channel by opening
of the cytosolic side of the lateral gate, thereby decreasing the
energetic barrier for translocation. The movement of helix 2,
implicated as part of this priming reaction, may provide a hydro-
phobic docking site for the arriving signal peptide in this region.
Importantly, this primed state leaves the channel largely closed
to membrane and entirely closed to the ER lumen.
In the second stage of activation, a suitable substrate can now
exploit the primed Sec61 by binding to and further opening the
lateral gate. Signal peptide engagement at the lateral gate results
in destabilization of the plug from the pore ring, either by steri-
cally pushing the plug out of position, or by opening of the lateral
gate, which shifts the helices surrounding the plug. Such a state
appears to have been captured at low resolution in the E. coli
system (Park et al., 2014). This model would rationalize why pro-
miscuously targeted nonclients are rejected by Sec61, prior to
gaining ac ess t the lumenal environment (Jungnickel and
Rapoport, 1995). The model would also explain how a small
molecule that seems to bind near the plug can allosterically
inhibit a signal sequence from successfully engaging Sec61
(Mackinnon et al., 2014).
Once the plug is destabilized, the translocating nascent chain
can enter the channel, which sterically prevents the plug from
adopting its steady-state conformation.Adynamicplugno longer
stabilizes the surrounding helices at the central pore, permitting
a more dynamic lateral gate. This flexibility may permit sampling
of the lipid bilayer by the translocating nascent chain, thereby al-
lowing suitably hydr phobic elements to insert in the membrane.
This model for activation provides one explanation for why trans-
membrane segments within a multispanning membrane protein
can be far less hydrophobic than those that engage the Sec61
channel de novo: the latter would need to fully open a nearly-
closed lateral g te stabilized by the plug, while the former could
take advantage of a gate made dynamic by plug displacement.
Both before and during translocation, a constant feature of
the native ribosome-translocon complex is the substantial gap
cytosol
lumen
TranslocatingQuiescent
H2/3
L6/7
Plug
*
Plug
Primed
H2/3
L6/7
L8/9
Figure 7. A Two-Step Model for Activation
of Sec61
Displayed here is a cut-away view of the model for
the Sec channel from the central pore toward the
lateral gate (dashed line). In the quiescent state
(left), approximated by a crystal structure of the
archaeal SecY complex (Van den Berg et al.,
2004), the Sec channel is closed to both the lumen
and lipid bilayer. The channel becomes primed
for protein translocation upon ribosome binding
(middle), triggering conformational changes in
Sec61 that crack the cytosolic side of the lateral
gate (demarcated by an asterisk). The movements
of helices 2 and 3 in this region may create an
in tial binding site for signal peptide recognition.
Engagement of the lateral gate by the signal peptide would open the channel toward themembrane and initiate translocation (not depicted; Park et al., 2014). The
translocating state of the active ribosome-Sec61 complex (right) contains a nascent polypeptide (teal) and is characterized by a dynamic plug domain and an
open conduit between the cytosol and lumen (teal dotted line).
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Figure S2. Refinement and 3D Classification Strategy, Related to Experimental Procedures
Each class in the displayed flowchart shows a cross section image of the respectivemap, the derivedmodel, anymask that was applied (red dashed line), and the
structure (s) derived from that class (red text). The complete data set containing 80,019 particles was refined using RELION (Scheres, 2012a, 2012b), resulting in
an initial reconstruction calculated to 3.4 A˚ resolution (Map 1). As the 40S subunit was in a variety of distinct conformations, a soft mask for the 60S subunit was
used throughout the refinement procedure (Map 2). Although this only resulted in a modest nominal increase in resolution (3.35 A˚), the observed density for the
60S subunit was improved compared to the complete refinement, and was used to build the 60S ribosomal proteins and RNA. In parallel, 3D classification of the
entire data set identified 13% of particles containing hybrid A/P- and P/E-site tRNAs and a nascent peptide. In order to supplement this relatively small class, an
additional data set was collected, resulting in a combined14,723 particles used to build the translating ribosome-Sec61 complex to 3.9 A˚ resolution (Map 3). The
remaining 87%of particles (69,464) were used to model the idle ribosome-Sec61 complex, lacking a nascent chain and tRNAs, to 3.4 A˚ resolution (Map 4). Within
this idle class, 36,667 particles containing eEF2, which stabilized both the stalk base proteins and the orientation of the 40S subunit relative to the 60S (Map 5).
This class of particles was used to build a model for the 40S ribosomal proteins and RNA at 3.5 A˚ resolution. The remaining idle particles either contained eEF2
bound in different ratcheted conformations (19%) or were devoid of tRNAs or factors (22%). All reported resolutions are determined using the gold-standard
Fourier Shell Correlation (FSC = 0.143) criterion (Scheres and Chen, 2012), and are shown in Figure S3.
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techniques (Scheres, 2010; Scheres, 2012b). Our initial data set
contained 80,019 ribosomal particles. In silico classification
of these particles (Figure S2) agrees with several aspects of its
biochemical characterization. First, nearly all ribosomes con-
tained a bound translocon, as classification of the final sample
could not isolate any translocon-free ribosomes. Second, while
the density for the area surrounding the translocon was hetero-
geneous due to a combination of accessory factors and the
detergent-lipid micelle, very high occupancy was observed for
the central Sec61 complex. Third, multiple classes of particles
could be sorted based on the conformation of the ribosome
and included translating and idle populations. The complete
data set and individual classes were separately analyzed to
extract their best features, which were incorporated into a com-
posite model for the complete 80S-Sec61 complex.
An initial reconstruction using the entire data set was calcu-
lated using a mask for the 60S subunit to avoid interference in
the angular assignment by the heterogeneous conformation of
the 40S. The resulting map, determined to 3.35 A˚ resolution,
was used to build the ribosomal RNA and proteins of the 60S
subunit. A distinctive class of !13% of particles contained two
tRNAs bound in the A/P and P/E hybrid state. These particles
were used to generate a 3.9 A˚ resolution map of the translating
ribosome-translocon complex, within which density for the
nascent polypeptide was observed throughout the ribosomal
tunnel. The remaining 69,464 particles lacking tRNA and a
nascent peptide were considered nontranslating ribosomes.
This class was processed using a 60Smask to build the idle ribo-
some-Sec61 map at 3.4 A˚ resolution. Finally, this idle class was
further subdivided by the degree of ribosomal ratcheting, and the
presence or absence of the translational GTPase eEF2. One of
these subclasses contained 36,667 particles and was used
to produce a 3.5 A˚ resolution map used for building of the 40S
ribosomal subunit and a well-ordered lateral stalk region. Thus,
by leveraging major advances in both image detection and
in silico analysis, a relatively small and heterogeneous data set
could be used to build a near-complete atomic model of the
mammalian 80S ribosome and high-resolution structures for
the Sec61 complex bound to the translating and idle ribosome
(see overview in Figure 1A). We will begin by presenting
the structure of the 80S ribosome, followed by discussion of
the Sec61 complex structure and its functional implications.
Throughout this study, we use the new unified nomenclature
for ribosomal proteins (see Table S1; Ban et al., 2014).
An Atomic Model of the Mammalian Ribosome
The porcine ribosome described in this study was determined
to an average resolution of 3.4 and 3.5 A˚ for the 60 and 40S,
respectively (Figure S3, Table S2), as judged by the ‘‘gold-stan-
dard’’ Fourier Shell Correlation (FSC = 0.143) criterion (Scheres
and Chen, 2012). Notably, much of the core of the 60S subunit
is at 3.0 A˚ resolution or better (Figure 1B), while the head of the
40S subunit, given its inherent flexibility, is at somewhat lower
resolution. The distal regions of several metazoan-specific
rRNA expansion segments, such as ES27L, protrude from the
ribosome and are presumably dynamic (Anger et al., 2013). As
in the earlier study, these regions of rRNA were not visualized
in our averaged maps. As the sample was prepared from an
actively translating tissue, there was no evidence for binding
of Stm1 or other sequestration factors that were observed in pre-
vious studies (Anger et al., 2013; Ben-Shem et al., 2011).
Using a recent model of the human ribosome generated at
!5.4 A˚ resolution as a starting point (Anger et al., 2013), we
have rebuilt each ribosomal protein and the rRNA, including
many amino acid side chains, RNA bases, and over 100 Mg2+
ions (Figure 2). Our density map allowed de novo building
of many regions that were previously approximated due to
lower resolution (Figure S4A). Additional eukaryote-specific
Figure 1. The Structure of a Mammalian Ribosome-Translocon Complex
(A) Model of the idle 80S ribosome in complex with Sec61, shown in red. The color scheme shown here is used throughout the manuscript: 40S rRNA is displayed
in orange, the 40S ribosomal proteins in brown, the 60S rRNA in cyan, and the 60S ribosomal proteins in dark blue. The region of the peptidyl transferase center
(PTC) is indicated.
(B) Cut view of the final unsharpened cryo-EM density map for both the idle 60S-Sec61 complex and the 40S subunit, colored by local resolution in A˚ (Kucukelbir
et al., 2014). Also see Figure S3.
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suggests that all peptides follow a universal path through the
ribosome, regardless of sequence or secondary structure
tendency.
The density for the peptide first encounters Sec61 adjacent to
loop 6/7, providing further evidence for the critical role this loop
plays in protein translocation (Raden et al., 2000; Cheng et al.,
2005). Several studies have hypothesized that there may be
communication between the ribosomal tunnel and translocon
to potentially prepare the channel for the handling of specific
upcoming sequence domains (Berndt et al., 2009; Liao et al.,
1997; Pool, 2009). As the rRNA lining the tunnel is relatively
fixed, it has been proposed that such communication would
involve the ribosomal proteins. The only protein that directly
contacts Sec61 and partially lines the tunnel is eL39, which is
positioned at the distal region of the tunnel (Figures 6A and
6B), where the peptide could begin to adopt secondary struc-
ture features. It is plausible that the conformation or hydropho-
bicity of the nascent peptide chain can be communicated via
eL39 directly to loop 6/7 of the translocon (Figure 6B; see Fig-
ure 4G for detail). Alternatively, this communication could be
transmitted via uL23, which forms extensive interactions with
both eL39 and Sec61 at the surface of the ribosome (Figure 6B).
The ability to visualize at near-atomic resolution both a defined
nascent polypeptide and the Sec61-interacting ribosomal pro-
teins surrounding the exit tunnel should allow these hypotheses
to be directly tested.
Structure of the Translating Ribosome-Sec61 Complex
Given the presence of the hybrid state tRNAs and nascent pep-
tide, this class of particles clearly contains an actively translating
ribosome-translocon complex. However, at a threshold at
which nascent chain density is visible in the ribosomal tunnel,
density was not observed within the Sec61 channel. One reason
may be that upon exit from the ribosome, nascent chains have
more conformational freedom inside a dynamic Sec61 than
within the ribosomal tunnel. We cannot exclude the alternative
possibility that nascent chains have slipped out of the Sec61
pore during sample preparation.
However, several lines of evidence suggest that most
translating ribosome-Sec61 complexes in our sample contain a
nascent chain within the Sec61 channel. First, the majority of
polypeptides in this sample represent soluble proteins of at least
!150 residues (Figure S1), a length more than sufficient to span
the aligned conduits of the ribosome and Sec61 channel. Sec-
ond, folded lumenal domains in most of these nascent chains
would prevent back sliding through the pore during solubili-
zation. Third, solubilization of pancreatic microsomes under
conditions comparable to those used here retain nearly all
endogenous nascent chains within the translocon (Matlack and
Walter, 1995). Fourth, sample preparation after solubilization
was very brief (<30 min) with minimal manipulations (Figures
S1C and S1D), in contrast to the multistep purification that re-
sulted in partial loss of nascent chains (Park et al., 2014). For
these reasons, we provisionally interpret this structure as an
‘‘active’’ Sec61 channel in the discussion below; definitive proof
must await a structure that permits direct nascent chain visuali-
zation. Though the resolution of this active Sec61 channel struc-
ture inmany regions does not allow the same type of atomic level
analysis as is possible for the idle translocon, it is still feasible to
examine its main characteristics (Figures S6A and S6B).
In agreement with earlier studies (Gogala et al., 2014), the
translocating state of Sec61 has no large-scale changes in its
architecture (Figure 6C). Helices 2, 7, and 8 do not appear to
have undergone substantial rearrangement, and the lateral
gate is largely unchanged from the primed state. Additionally,
helices 1 and 10 have shifted (Figure 6C), and the density for helix
3 is very weak (Figure S6A), suggesting it has becomemobile. At
a threshold where all the surrounding helices were visualized,
density for the plug was no longer visible in the center of the
channel (Figure 6D) and a continuous conduit now runs through
Figure 6. The Translating Ribosome-Sec61 Complex
(A) Cryo-EM density within the ribosomal exit tunnel for the nascent peptide
(cyan), which spans from the A/P tRNA to Sec61. The location of ribosomal
protein eL39, which lines the exit tunnel, is indicated.
(B) Ribosomal protein eL39 (bright blue) forms part of the exit tunnel (high-
lighted in cyan) and interacts with loop 6/7 of Sec61. Ribosomal protein uL23
(dark blue) contacts both eL39 and loop 8/9 of Sec61.
(C) Comparison of the Sec61 channel structures bound to idle or translating
ribosome, showing movements in helices 1 and 10, which may be important
for allowing translocation of the nascent polypeptide. Also see Figure S6.
(D) Rigid-body fitting of the idle Sec61 model (red) into the density for the
translating Sec61-ribosome complex demonstrates that the plug is not visible
in its canonical location. Displayed is an unsharpened map in which the
disordered density for the detergent micelle has been removed using Chimera
(Goddard et al., 2007).
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Sec61a. The central pore was sufficiently large to house a model
of an extended polypeptide without clashes.
While the plug’s canonical position was not occupied in the
active state, we could not unambiguously assign it to an alternate
location. It is possible the plug adopts a variety of conformations
in this sample (given the heterogeneous sequences of translo-
cating nascent chains) or becomes disordered to allow translo-
cation. Given that the plug can be crosslinked to several dispa-
rate residues within an active SecY, it is likely dynamic once
freed from its interactions with the pore ring. This flexibility may
be facilitated by the observed movements in helix 1. In the static
situation of a stalled nascent chain (Gogala et al., 2014), the plug
may settle at its lowest energy state, perhaps explaining why it
was apparently seen near its original location. However steric
constraints would require at least a nominal shift in the plug to
accommodate the nascent peptide within the central pore.
Although fewer particles for the active Sec61 complex led to a
lower-resolution map than that for the idle complex, some areas
are better resolved than others (Figures S6A and S6B). Helices 6-
9, along with loops 6/7 and 8/9, display the highest resolution
within the structure as judged by atomic B-factor (Figure S6C).
This provides confidence in concluding that this part of Sec61
has few if any substantive conformational changes relative to
the idle state. Thus, the C-terminal half of Sec61 effectively forms
a stable platform for ribosome interaction.
By contrast, the density for helices 2-4 is significantly weaker
than for either this same region in the idle Sec61 structure, or for
helices 6-9 in the active structure (Figure S6). This observation
strongly argues that the position of helices 2-4 in the active
Sec61 is heterogeneous. Several nonmutually exclusive expla-
nations are possible: (i) heterogeneous clients at different stages
of transloction; (ii) different accessory proteins acting during
translocation; and (iii) inherent flexibility in this region when the
plug is displaced. Irrespective of the specific explanation (s), it
would seem clear that helices 6-9 provide a ribosome-stabilized
fulcrum, which allowsmovements within the remaining portion of
the molecule to accommodate the nascent chain.
Implications for Cotranslational Protein Translocation
The structures described here help refine our understanding
of several steps during cotranslational protein translocation
and provide mechanistic insights into the two stages for fully
activating the Sec61 channel (Figure 7). In the quiescent state
presumably represented by the isolated crystal structure (Van
den Berg et al., 2004), the channel is fully closed to both the
lumen and lipid bilayer. The first stage of activation involves
binding of the ribosome, which primes the channel by opening
of the cytosolic side of the lateral gate, thereby decreasing the
energetic barrier for translocation. The movement of helix 2,
implicated as part of this priming reaction, may provide a hydro-
phobic docking site for the arriving signal peptide in this region.
Importantly, this primed state leaves the channel largely closed
to membrane and entirely closed to the ER lumen.
In the second stage of activation, a suitable substrate can now
exploit the primed Sec61 by binding to and further opening the
lateral gate. Signal peptide engagement at the lateral gate results
in destabilization of the plug from the pore ring, either by steri-
cally pushing the plug out of position, or by opening of the lateral
gate, which shifts the helices surrounding the plug. Such a state
appears to have been captured at low resolution in the E. coli
system (Park et al., 2014). This model would rationalize why pro-
miscuously targeted nonclients are rejected by Sec61, prior to
gaining access to the lumenal environment (Jungnickel and
Rapoport, 1995). The model would also explain how a small
molecule that seems to bind near the plug can allosterically
inhibit a signal sequence from successfully engaging Sec61
(Mackinnon et al., 2014).
Once the plug is destabilized, the translocating nascent chain
can enter the channel, which sterically prevents the plug from
adopting its steady-state conformation.Adynamicplugno longer
stabilizes the surrounding helices at the central pore, permitting
a more dynamic lateral gate. This flexibility may permit sampling
of the lipid bilayer by the translocating nascent chain, thereby al-
lowing suitably hydrophobic elements to insert in the membrane.
This model for activation provides one explanation for why trans-
membrane segments within a multispanning membrane protein
can be far less hydrophobic than those that engage the Sec61
channel de novo: the latter would need to fully open a nearly-
closed lateral gate stabilized by the plug, while the former could
take advantage of a gate made dynamic by plug displacement.
Both before and during translocation, a constant feature of
the native ribosome-translocon complex is the substantial gap
cytosol
lumen
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Figure 7. A Two-Step Model for Activation
of Sec61
Displayed here is a cut-away view of the model for
the Sec channel from the central pore toward the
lateral gate (dashed line). In the quiescent state
(left), approximated by a crystal structure of the
archaeal SecY complex (Van den Berg et al.,
2004), the Sec channel is closed to both the lumen
and lipid bilayer. The channel becomes primed
for protein translocation upon ribosome binding
(middle), triggering conformational changes in
Sec61 that crack the cytosolic side of the lateral
gate (demarcated by an asterisk). The movements
of helices 2 and 3 in this region may create an
initial binding site for signal peptide recognition.
Engagement of the lateral gate by the signal peptide would open the channel toward themembrane and initiate translocation (not depicted; Park et al., 2014). The
translocating state of the active ribosome-Sec61 complex (right) contains a nascent polypeptide (teal) and is characterized by a dynamic plug domain and an
open conduit between the cytosol and lumen (teal dotted line).
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Figure 2. Defects in the Signal Sequence or in a Targeting Factor, SRP, Lead to Decreased Levels of a Secretory Protein mRNA
(A and B) Effect of deletions in signal sequence on PPL mRNA levels. PPL and control mRNAs were analyzed by northern blot (A) or qPCR (B; n = 9, mean ± SD)
42 hr after transfection of HeLa Tet-On with WT and mutated PPL plasmids.
(C) Presence of a mutated PPL signal sequence (PPL-D4L) in hybrid proteins containing the mature part of a1-antitrypsin (AT) or carbonic anhydrase IV (CA4) is
sufficient to trigger mRNA depletion. mRNA levels measured by qPCR (n = 3, mean ± SD) are shown relatively to mRNA levels of corresponding hybrid proteins
containing WT PPL signal sequence (PPL-WT).
(D) Deletions (indicated by dashes) in the natural signal sequences of secretory proteins AT or CA4.
(E) Deletions in the hydrophobic core of natural signal sequences of AT or CA4 proteins lead to a decrease in their mRNA levels. Graph shows mRNA levels
measured by qPCR (n = 3, mean ± SD).
(F) Scheme shows differences in biogenesis of secretory and cytosolic proteins. When the signal sequence of a secretory protein emerges from the ribosomal
tunnel it is recognized by SRP, and the complex is targeted to SRP receptor and finally to a translocon in ER membrane. Nascent chains of cytosolic proteins do
not have signal sequences, however, their nascent chains are recognized by ribosome-associated chaperones and that help them fold in the cytosol.
(G and H) SRP depletion causes a reduction in the level of secretory protein mRNA. Detection of PPL, and actin mRNAs (northern blot), SRP54, PPL and actin
proteins (western blot) in HeLa Tet-On cells transfected with siRNA for SRP54 andWT orD4L PPL plasmids as indicated (G). Quantification ofWT PPL (open bars)
or D4L mutant (black bars) mRNAs by qPCR in independent sets of SRP54 knockdown experiments (n = 3, mean ± SD) (H).
(I) Knockdown of SRP receptor subunits SRa and SRb, or translocon component, Sec61a, does not affect PPL mRNA level (qPCR, n = 3, mean ± SD). WT PPL
(open bars), D4L mutant (black bars).
(legend continued on next page)
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SUMMARY
Misfolded proteins are often cytotoxic, unless
cellular systems prevent their accumulation. Data
presented here uncover a mechanism by which de-
fects in secretory proteins lead to a dramatic reduc-
tion in their mRNAs and protein expression. When
mutant signal sequences fail to bind to the signal
recognition particle (SRP) at the ribosome exit site,
the nascent chain instead contacts Argonaute2
(Ago2), and the mutant mRNAs are specifically
degraded. Severity of signal sequence mutations
correlated with increased proximity of Ago2 to
nascent chain and mRNA degradation. Ago2 knock-
down inhibited degradation of the mutant mRNA,
while overexpression of Ago2 or knockdown of
SRP54 promoted degradation of secretory protein
mRNA. The results reveal a previously unappreciated
general mechanism of translational quality control, in
which specific mRNA degradation preemptively
regulates aberrant protein production (RAPP).
INTRODUCTION
The cytotoxicity of misfolded and mistargeted proteins is coun-
tered by cellular systems that prevent their accumulation (Stefani
and Dobson, 2003). Cells have strict quality-control systems in
the cytosol and in the endoplasmic reticulum (ER) to distinguish
properly folded proteins from misfolded (Buchberger et al.,
2010; Ellgaard and Helenius, 2003). Secretory and membrane
proteins that are not transported to their proper cellular destina-
tions are either degraded by the ER associated degradation
(ERAD) pathway (Brodsky, 2012; Smith et al., 2011) or form inclu-
sions (Kopito, 2000). When proteins are successfully translo-
cated from the cytosol to the ER, but are not transported further
due to misfolding in stress conditions, the unfolded protein
response (UPR) is activated. UPR involves activation of stress
response genes, general downregulation of protein synthesis,
and degradation of misfolded ER proteins (Schro¨der and Kauf-
man, 2005; Walter and Ron, 2011). Another mechanism that
prevents accumulation of misfolded proteins in the ER during
UPR is regulated ire1-dependent decay (RIDD) (Hollien et al.,
2009; Hollien andWeissman, 2006). This mechanism is activated
under conditions of general ER stress and reduces the quantity
of many mRNAs that encode secretory proteins. Thus, these
processes are general responses to stress conditions and
have not evolved to specifically triage an individual mutant pro-
tein that misfolds. Whether cells can specifically prevent the syn-
thesis of ‘‘unwanted,’’ and potentially hazardous proteins
derived from mutated or foreign mRNAs is only poorly under-
stood. If mutant proteins do not fold properly or fail to be deliv-
ered to the appropriate cellular compartment, they can be
removed by the proteasome system (Ward et al., 1995). Such a
posttranslational mechanism, however, does not prevent
continued de novo production of the mutant gene product.
Currently known systems of mRNA quality control, nonsense
mediated decay (NMD), nonstop decay (NSD), and no-go decay
(NGD), detect only profound defects, including premature stop
codons, lack of a natural stop codon, or stalled ribosomes
(Doma and Parker, 2007; Shoemaker and Green, 2012). These
146 Cell 156, 146–157, January 16, 2014 ª2014 Elsevier Inc.
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
is required for the mechanism of catalysis by the NatA complex, and 
Naa10p is likely to represent an active GNAT fold. Consistent with 
this hypothesis, a backbone alignment of key active site elements in 
active Naa10p with the corresponding region in the independently 
active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence 
shows a high degree of structural conservation (r.m.s. deviation of 
1.52 Å). The corresponding alignment of the complexed and uncom-
plexed forms of Naa10p showed less structural conservation, with an 
r.m.s. deviation of 2.43 Å (Fig. 2e).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide bind-
ing by NatA, and in particular how, unlike most other NATs, it is able 
to accommodate a number of nonmethionine N-terminal substrates, 
we synthesized a bisubstrate conjugate in which CoA is covalently 
linked to a biologically relevant substrate peptide fragment with the 
sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition stud-
ies with CoA-SASEA and with a control compound, acetonyl CoA, 
which is a nonhydrolyzable acetyl CoA analog (Fig. 3a). Half-maxi-
mum inhibitory concentration (IC50) determinations revealed that 
CoA-SASEA had an IC50 of 1.4 o 1.0 MM, whereas acetonyl CoA 
had an IC50 of 380 o 10 MM (Fig. 3b). To assess the specificity of this 
inhibitor toward NatA, we also calculated IC50 values of CoA-SASEA 
and acetonyl CoA with NAA50, a NAT that requires a substrate 
N-terminal methionine residue. We found that CoA-SASEA has an 
IC50 of 11 o 2 MM, whereas acetonyl CoA has an IC50 of 130 o 12 MM 
(Fig. 3b). With NAA50, the addition of a SASEA peptide portion 
was able to increase the potency of acetonyl CoA by only about ten-
fold, whereas with NatA this peptide addition exhibited an increase 
in potency of about 300-fold. The greater potency of acetonyl CoA 
with NAA50 over Naa10p can be explained by the stronger binding of 
acetyl CoA to NAA50 (Km = 27 o 2 MM) than to Naa10p (Km = 59 o 
5 MM). The markedly higher potency of the CoA-SASEA inhibitor 
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Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to 
acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered 
loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and 
d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p A1–A2 and Naa15p 
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Chemical Approaches for the Detection and Synthesis of
Acetylated Proteins
Yu-Ying Yang and Howard C. Hang*[a]
Introduction
Protein acetylation describes the covalent modification of pro-
tein with an acetyl group (Scheme 1). Acetylation can modu-
late protein–protein interactions, protein stability and signal
transduction in cells to regulate physiological responses and
disease progression. Amongst the different types of protein
acetylation, lysine acetylation has emerged as a major post-
translational modification (PTM) in both eukaryotes and prokar-
yotes (Scheme 1A). Notably, reversible lysine acetylation of his-
tones enables epigenetic regulation of gene expression in eu-
karyotes.[1–3] The recent discovery of many other lysine-acety-
lated proteins by mass spectrometry (MS) suggests lysine ace-
tylation is involved in diverse functions in cells.[4–6] MS-based
proteomics has also revealed thousands of proteins bearing N-
terminal acetylation that might serve as a key mechanism for
controlling protein stability in eukaryotes (Scheme 1B).[7–9] In
addition, acetylation of serine and threonine residues has been
discovered in eukaryotic proteins in the context of bacterial in-
fection in which secretion of bacterial acetyltransferases into
host cells modulates inflammatory responses (Scheme 1C).[10,11]
Given the prevalence and diversity of protein acetylation,
robust methods are needed for the detection and synthesis of
acetylated proteins to unravel
their biological functions and
underlying regulatory mecha-
nisms. Herein, we survey recent
chemical approaches to monitor
and discover acetylated proteins
as well as semisynthetic meth-
ods to produce homogeneously
acetylated proteins.
Lysine Acetylation
Lysine acetylation is a reversible
PTM that is tightly regulated by
lysine acetyltransferases (KATs)[12]
and lysine deacetylases
(KDACs)[13] in both prokaryotic
and eukaryotic cells
(Scheme 1A). As a highly dynam-
ic modification like phosphoryla-
tion, lysine acetylation can regu-
late protein functions by two
major mechanisms. Firstly, acety-
lation results in neutralization of
the positive charge on lysine res-
idues that can alter protein
structure, folding, and interac-
tion with other proteins. Second-
ly, acetyllysine can serve as a recognition motif to interact with
bromodomain-containing proteins[14,15] or other proteins that
can specifically recognize acetyllysine residues[16] to recruit pro-
tein complexes for downstream signaling functions. Lysine ace-
tylation was initially identified on histones by Allfrey and co-
workers in 1964.[17] Histone acetylation typically results in a
more relaxed chromatin structure and permissive environment
for access of transcription factors to activate gene expression
Scheme 1. Different classes of protein acetylation. A) Lysine acetylation is a reversible PTM that is tightly regulated
by KATs and KDACs. Propionylation and butyrylation have also been described on lysine residues. B) N-terminal
acetylation is regulated by N-acetyltransferases. C) Serine and threonine acetylation are executed by secreted bac-
terial effector proteins during infection of eukaryotic cells.
[a] Dr. Y.-Y. Yang, Prof. H. C. Hang
Laboratory of Chemical Biology and Microbial Pathogenesis
The Rockefeller University
1230 York Avenue, New York, NY 10065 (USA)
E-mail : hhang@mail.rockefeller.edu
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NatA	(Naa10/Naa15)
NatA	consists	of	
• Naa15	(auxiliary	subunit;100	kDa)
• Naa10	(catalytical	subunit;	
26	kDa)
• Naa50	(catalytical	subunit	NatE)
• HYPK
• others?
NatA function
• generation and differentiation of neurons
• b-Catenin transcriptional activity
• cyclin D1 regulation
• NF- kB /DNA-damage response pathways
• cellular hypoxia
• apoptosis & cancer 
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
is required for the mechanism of catalysis by the NatA complex, and 
Naa10p is likely to represent an active GNAT fold. Consistent with 
this hypothesis, a backbone alignment of key active site elements in 
active Naa10p with the corresponding region in the independently 
active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence 
shows a high degree of structural conservation (r.m.s. deviation of 
1.52 Å). The corresponding alignment of the complexed and uncom-
plexed forms of Naa10p showed less structural conservation, with an 
r.m.s. deviation of 2.43 Å (Fig. 2e).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide bind-
ing by NatA, and in particular how, unlike most other NATs, it is able 
to accommodate a number of nonmethionine N-terminal substrates, 
we synthesized a bisubstrate conjugate in which CoA is covalently 
linked to a biologically relevant substrate peptide fragment with the 
sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition stud-
ies with CoA-SASEA and with a control compound, acetonyl CoA, 
which is a nonhydrolyzable acetyl CoA analog (Fig. 3a). Half-maxi-
mum inhibitory concentration (IC50) determinations revealed that 
CoA-SASEA had an IC50 of 1.4 o 1.0 MM, whereas acetonyl CoA 
had an IC50 of 380 o 10 MM (Fig. 3b). To assess the specificity of this 
inhibitor toward NatA, we also calculated IC50 values of CoA-SASEA 
and acetonyl CoA with NAA50, a NAT that requires a substrate 
N-terminal methionine residue. We found that CoA-SASEA has an 
IC50 of 11 o 2 MM, whereas acetonyl CoA has an IC50 of 130 o 12 MM 
(Fig. 3b). With NAA50, the addition of a SASEA peptide portion 
was able to increase the potency of acetonyl CoA by only about ten-
fold, whereas with NatA this peptide addition exhibited an increase 
in potency of about 300-fold. The greater potency of acetonyl CoA 
with NAA50 over Naa10p can be explained by the stronger binding of 
acetyl CoA to NAA50 (Km = 27 o 2 MM) than to Naa10p (Km = 59 o 
5 MM). The markedly higher potency of the CoA-SASEA inhibitor 
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Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to 
acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered 
loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and 
d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p A1–A2 and Naa15p 
A29–A30. (d) Zoom view of the intersubunit interface at the C-terminal region of Naa10p A1 and the Naa15p A25–A27–A28 helices.
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Crystal	Structure	of	NAA50
and C).3 There are no substantial interactions beyond the leu-
cine backbone carbonyl group seen in the structure. The overall
thermal B-factor of the peptide is 73.9, which is high in relation
to the overall thermal B-factor of the protein, 55. This discrep-
ancy can be accounted for by the skewed nature of theB-factors
of the individual residues of the peptide. Met1 has a B-factor of
62, and this value increases for each residue of the peptide that
extends out of the binding pocket, with the Pro4B-factor reach-
ing 93. For comparison, the atoms of CoA have an average
B-factor of 50. Superposition of the ternary complex with the
binary Naa50p!acetyl-CoA complex (Protein Data Bank code
2OB0) showed no significant structural rearrangement upon
substrate peptide binding (supplemental Fig. 1), further reveal-
ing that Naa50p does not undergo significant structural change
upon protein substrate binding.
The Naa50p Protein Substrate-binding Site Is Ideally Suited
to Accommodate an !-Amino Group of an N-terminal
Methionine—The N-terminal peptide substrate points into the
protein active site, with the backbone roughly perpendicular to
the central "-sheet and parallel to the pantothenate arm of the
CoA (Figs. 1B and 2A). The peptide is anchored to the protein
through a series of hydrogen bonds between the side chains of
Tyr-31 and Tyr-139 and the backbone carbonyl atoms of
Met-75 and His-112 (Fig. 2C). The N-terminal methionine sits
in a hydrophobic pocket composed of Phe-27, Pro-28, and
Val-29 from the !1-!2 loop and Tyr-139 and Ile-142 from the
"6-"7 hairpin loop, which each make van der Waals contacts
withMet1 of the peptide. Leu2 also sits in a hydrophobic pocket
formed by Tyr-31 and Phe-35 from the !1-!2 loop segment,
Tyr-138 from the "6-"7 hairpin loop, and Tyr-73 and Met-75
from the "4 strand (Fig. 2C). There are also hydrophilic groups
in the vicinity of Leu2 such as the hydroxyls of Tyr-73 and Tyr-
138 and the guanidinium group of Arg-62 (Fig. 2C), which pro-
vides an explanation for the ability of Naa50p to acetylate a
substrate with a hydrophilic residue at the second position.
Consistent with the importance of residues that contact the
peptide, each of these residues is highly conserved within the
Naa50p orthologs from other species (Fig. 2D). In particular,
the residues that contact the peptide backbone (Tyr-31, Met-
75, His-112, and Tyr-139) and Met1 (Phe-27, Pro-28, Val-29,
Tyr-139, and Ile-142) are strictly conserved, and residues that
contact Leu2 (Tyr-31, Phe-35, Tyr-73, Met-75, and Tyr-138)
are strictly or highly conserved (Fig. 2D).
To establish directly the functional importance of Naa50p
residues that appear to make important peptide substrate con-
tacts in the crystal structure, we targeted several of these resi-
dues for mutagenesis, followed by enzymatic characterization
of the mutant proteins. Each mutated residue was changed to
alanine, and the catalytic efficiency of each mutant was deter-
mined and compared with that of the wild-type protein. Each
mutantwas purified to homogeneity and exhibited gel filtration
chromatography elution profiles identical to that of the wild-
type construct. To confirm further that the mutant proteins
were folded properly, they were subjected to circular dichroism
experiments, each revealing a similar spectrum to thewild-type
protein (data not shown). Notably, each of the mutant proteins
showed defects in catalytic efficiency, with most of the mutant
proteins showing no detectable activity (Fig. 3 and Table 2). Of
the residues that contact the peptide backbone, Tyr-31, His-
112, and Tyr-139 were mutated, and each of these mutants
showed no detectable activity, arguing for the importance of
these residues for backbone interaction, although Tyr-31 also
participates in Leu2 peptide contact, and His-112 likely partic-
ipates directly in catalysis, as will be described below (Fig. 3 and
Table 2). Of the residues that contact Met1 of the peptide, the
Phe-27 mutant showed no detectable activity, whereas the
Pro-28 andVal-29mutants showed at least an 85% reduction in
activity. The Tyr-139 mutant showed no detectable activity,
and the Ile-142mutant retained!40% activity (Fig. 3 andTable
2). Mutants of Leu2 peptide contact residues Tyr-31, Phe-35,
andTyr-73 each showed no detectable activity (Fig. 3 andTable
2). Taken together, the results from the structure-based
mutagenesis are consistent with the functional importance of
the protein-peptide substrate interactions observed in the crys-
tal structure.
Tyr-73 and His-112 Likely Play Catalytic Roles through an
Ordered Water Molecule—Analysis of the Naa50p active site
revealed that only two residues are in position to function in
3 The positions of residues in the peptide substrate are indicated by super-
script numbers, and those in the protein enzyme are indicated by hyphen-
ated full-size numbers.
FIGURE 1.Overall structure of the ternary Naa50p!CoA!peptide complex.
A, structure of the ternary complex showing Naa50p in teal; CoA asmagenta
stickswith carbon, nitrogen, and sulfur atoms in Corey-Pauling-Koltun color-
ing; and the substrate peptide as yellow sticks with carbon, nitrogen, and
sulfur atoms in Corey-Pauling-Koltun coloring. Substrate peptide electron
density obtained from a composite omit map (blue) is shown contoured to
1.5#. B, superposition of the ternary Naa50p complex with the ternary Gcn5
HAT. The Gcn5 enzyme and accompanying substrate peptide (orange) are
shown in schematic format. The substrate peptides for each enzyme are
shown as thicker schematics for clarity.
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62, and this valu increases for each residue of t e peptid that
extends out of the binding pocket, with the Pro4B-factor reach-
ing 93. For comparison, the atoms of CoA have an average
B-factor of 50. Superposition of the ternary complex with the
binary Naa50p!acetyl-CoA complex (Protein Data Bank code
2OB0) showed no sig ificant structural re rrangement upon
substrate peptide binding (supplemental Fig. 1), further reveal-
ing that Naa50p does not undergo significant structural change
upon protein substrate binding.
The Naa50p Protein Substrate-binding Site Is Ideally Suited
to Accommodate an !-Amino Group of an N-terminal
Methionine—The N-terminal peptide substrate points into the
protein active site, with the backbone roughly perpendicular to
the central "-sheet and parallel to the pantothenate arm of the
CoA (Figs. 1B and 2A). The peptide is anchored to the protein
through a series of hydrogen bonds between the side chains of
Tyr-31 and Tyr-139 and the backbone carbonyl atoms of
Met-75 and His-112 (Fig. 2C). The N-terminal methionine sits
in a hydrophobic pocket composed of Phe-27, Pro-28, and
Val-29 from the !1-!2 loop and Tyr-139 and Ile-142 from the
"6-"7 hairpin loop, which each make van der Waals contacts
withMet1 of the peptide. Leu2 also sits in a hydrophobic pocket
formed by Tyr-31 and Phe-35 from the !1-!2 loop segment,
Tyr-138 from the "6-"7 hairpin loop, and Tyr-73 and Met-75
from the "4 strand (Fig. 2C). There are also hydrophilic groups
in the vicinity of Leu2 such as the hydroxyls of Tyr-73 and Tyr-
138 and the guanidinium group of Arg-62 (Fig. 2C), which pro-
vides an explanation for the ability of Naa50p to acetylate a
substrate with a hydrophilic residue at the second position.
Consistent with the importance of residues that contact the
peptide, each of these residues is highly conserved within the
Naa50p orthologs from other species (Fig. 2D). In particular,
the residues that co tact the peptide backbone (Tyr-31, Met-
75, His-112, and Tyr-139) and Met1 (Phe-27, Pro-28, Val-29,
Tyr-139, and Ile-142) are strictly conserved, and residues that
con act Leu2 (Tyr-31, P e-35, Tyr-73, Met-75, and Tyr-138)
are strictly or highly conserved (Fig. 2D).
To establish directly t e functional importance of Naa50p
residues that appear to make important peptide substrate con-
tacts in the crystal structure, we targeted several of these resi-
dues for mutagenesis, foll wed by enzymatic characterization
of the mutant proteins. Each mutated residue was changed to
alanine, and th catalytic efficiency of each mutant was deter-
mined and compared with that of the wild-type protein. Each
mutantwas purified to homogeneity and exhibited gel filtration
chromatography elution profiles identical to that of the wild-
type construct. To confirm further that the mutant proteins
we e folded roperly, they were subjected to circular dichroism
experiments, each revealing a similar spectrum to thewild-type
protein (data not shown). Notably, each of the mutant proteins
showed defe ts in atalytic efficiency, with most of the mutant
proteins showing no detectable activity (Fig. 3 and Table 2). Of
the residues tha con act th peptide backbone, Tyr-31, His-
112, and Tyr-139 were mutated, and each of these mutants
showed no detectable activity, arguing for the importance of
these residues for backbo e interaction, although Tyr-31 also
participates in Leu2 peptide contact, and His-112 likely partic-
ipates dir ctly in catalysis, as will be described below (Fig. 3 and
Table 2). Of the residues that contact Met1 of the peptide, the
Phe-27 mutant showed no detectable activity, whereas the
Pro-28 andVal-29mutants showed at least an 85% reduction in
activity. The Tyr-139 mutant showed no detectable activity,
and the Ile-142mutan retained!40% activity (Fig. 3 andTable
2). Mutants of Leu2 peptide contact residues Tyr-31, Phe-35,
andTyr-73 each showed no detectable activity (Fig. 3 andTable
2). Taken together, the results from the structure-based
mutagenesis are consistent with the functional importance of
the protein-peptide substrate interactions observed in the crys-
tal structure.
Tyr-73 and His-112 Likely Pl y Catalytic Roles through an
Ordered Water Molecule—Analysis of the Naa50p active site
revealed that only two residues are in position to function in
3 The positions of residues in th eptide ubstrate ar indicated by super-
script numbers, and those in the protein enzyme are indicated by hyphen-
ated full-size numbers.
FIGURE 1.Overall structure of the ternary Naa50p!CoA!peptide compl x.
A, structure of the ternary complex showing Naa50p in teal; CoA asmagen a
stickswith carbon, nitrogen, and sulfur atoms in Corey-Pauling-Koltun color-
ing; and the substrate peptide as yellow sticks with carbon, nitrogen, and
sulfur atoms in Corey-Pauling-Koltun coloring. Substrate peptide lectron
density obtained from a composite omit map (blue) is shown contoured to
1.5#. B, superposition of the ternary Naa50p complex with the terna y Gcn5
HAT. The Gcn5 enzyme and accompanying substrate peptide (ora ge) ar
shown in schematic format. The substrate peptides for each enzyme are
shown as thicker schematics for clarity.
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Structure of a Ternary Naa50p (NAT5/SAN) N-t rminal
Acetyltransferase Complex Reveals the Molecular Basis for
Substrate-specific Acetylation*□S
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Background: The human Na 50p N-termi l acetyltransferase acetylates proteins on the !-amino group of methionine
residues to regulate genome integrity and has elevated activity in cancer.
Results:We report the structure of the Naa50p"CoA"peptide complex and related biochemistry.
Conclusion:We reveal the molecular basis for substrate-specific acetylation by Naa50p.
Significance: We provide a molecular scaffold for the design of Naa50p-specific inhibitors with possible therapeutic
application .
The co-translational modification of N-terminal acetylation
is ubiquitous among eukaryotes and has been reported to have a
wide range of biological effects. The human N-terminal acetyl-
transferase (NAT)Naa50p (NAT5/SAN) acetylates the!-amino
group of proteins containing an N-terminal methionine residue
and is essential f r proper sister chromatid cohesio and chro-
mosome condensation. The elevated activity of NATs has also
been correlated with cancer, making these enzymes attractive
therapeutic targets. We report the x-ray crystal structure of
Naa50p bound to a native substrate peptide fragment and CoA.
We found that thepeptidebackboneof the substrate is anchored
to theprotein through a series of backbonehydrogenbondswith
the first methionine residue specified through multiple van der
Waals contacts, together creating an !-amino methionine-spe-
cific pocket. We also employed structure-based mutagenesis;
the results support the importance of the !-amino methionine-
specific pocket of Naa50p and are consist nt with the proposal
that conserved histidine and tyrosine residues play important
catalytic roles. Superposition of the te nary Naa50p complex
with the peptide-boundGcn5histone acetyltransferase revealed
that the two enzymes share a Gcn5-related N-acetyltransferase
fold but differ in th r respective subs rate-binding grooves such
that Naa50p can accommodate only an !-amino substrate and
not a side chain lysine substrate that is acetylated by lysine
acetyltransferase enzymes such as Gcn5. The structure of the
ternary Naa50p complex also provides the first molecular
scaffold for the design of NAT-specific small molecule inhibi-
tors with possible therapeutic applications.
Protein acetylation is one of the most common covalent
modifications found in the proteome (1). In this process, an
acetyl group is transferred from acetyl-CoA to an !-amino
group at the N terminus of a protein or an "-amino group on a
lysine side chain. Lysine acetyltransferase enzymes have been
more extensively characterized than N- erminal acetyltrans-
ferase (NAT)2 enzymes at the biochemical, enzymological, and
structural levels (2). To date, only one structure of a prokaryotic
NAT has been reported (3), and the mechanisms of substrate-
specific recognition and catalysis used by th se enzymes remain
poorly understood.
In eukaryotes, N-terminal acetylation displays a wide range
of functional effects varying on a case-by-case basis (4).
Rece tly, thismodificationwas shown to serve as a degradation
signal for individu l proteins (5) and also to prevent proper
post-translational translocation through the endoplasmic
reticulum (6). I euk ryotes, multiple protei complexes are
capable of performing N-terminal ace ylation, the most pro-
miscuous an well characterized of whi h is the NatA complex
(7–9). This protein complex contains two catalytic subunits,
Naa10p (ARD1) and Naa50p, and two auxiliary subunits,
Naa15p (NATH (N-acetyltransferase human)) and HYPK,
which associate with the ribosome (9–11). The human and
fruit fly Naa50p enzymes are essential for normal sister chro-
matid cohesion and chromosome condensation, but the NatA
complex was not implicated in this phenotype, suggesting that
this is attributed solely byNaa50p-mediatedNATactivity inde-
pendent of the complex (12–14). However, the responsible sub-
strate potentially requiring N-terminal acetylation for proper
functioning remains to be identified. Interestingly, NatA sub-
units have been shown to be overexpressed in a number of
* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
Grant GM060293 (to R. M.) and Training Grant GM071339 (to G. L.). This
work was also supported by the Research Council of Norway and the Nor-
wegian Cancer Society (to T. A.).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Fig. 1.
Theatomic coordinates and structure factors (code 3TFY) havebeendeposited in
the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,
Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
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related N-acetyltransferase; HAT, histone acetyltransferase.
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The co-translational modification of N-terminal acetylation
is ubiquitous among eukaryotes and has been re orted to have a
wide range of biological effects. The human N-terminal ace yl-
transferase (NAT)Naa50p (NAT5/SAN) acetylates the!-amino
group of proteins containing an N-terminal methionine residue
and is essential for proper sister chromatid cohesion and chro-
mosome condensation. The elevated activity of NATs has also
been correlated with cancer, making these enzymes attractive
therapeutic targets. We report the x-ray crystal structure of
Naa50p bound to a native substrate peptide fragment and CoA.
We found that thepeptidebackboneof the substrate is anchored
to theprotein through a series of backbonehydrogenbondswith
the first methionine residue specified through multiple van der
Waals contacts, together creating an !-amino methionine-spe-
cific pocket. We also employed structure-based mutagenesis;
the results support the importance of the !-amino methionine-
specific pocket of Naa50p and are consistent with the proposal
that conserved histidine and tyrosine residues play important
catalytic roles. Superposition of the ternary Naa50p complex
with the peptide-boundGcn5histone acetyltransferase revealed
that the two enzymes share a Gcn5-related N-acetyltransferase
fold but differ in their respective substrate-binding grooves such
that Naa50p can accommodate only an !-amino substrate and
not a side chain lysine substrate that is acetylated by lysine
acetyltransferase enzymes such as Gcn5. The structure of the
ternary Naa50p complex also provides the first molecular
scaffold for the design of NAT-specific s all molecule inhibi-
tors w possi le thera utic applications.
Protein acetylation is one of the most common covalent
modifications found in the proteome (1). In this process, an
acetyl group is transferred from acetyl-CoA to an !-amino
group at the N termi us of a protein or an "-amino group on a
lysine side ch in. Lysine acetyltransferase enzym s have been
more extensively characterized than N-terminal a etyltrans-
ferase (NAT)2 enzymes at the biochemical, enzymological, and
structural levels (2). To date, only one structure of a prokaryotic
NAT has been reported (3), and the mechanisms of substrate-
specific recognition and catalysis used by these enzymes remain
poorly understood.
In eukaryotes, N-terminal acetylation displays a wide range
of functio al effects varying on a case-by-case basis (4).
Recently, thismodificationwas shown to serve as a degradation
signal for individual proteins (5) and also to prevent proper
post-translational translocation through the endoplasmic
reticulum (6). In eukaryotes, multiple protein complexes are
capable of performing N-terminal acetylation, the most pro-
miscuous and well characterized of which is the NatA complex
(7–9). This protein complex contains two catalytic subunits,
Naa10p (ARD1) and Naa50p, and two auxiliary subunits,
Naa15p (NATH (N-acetyltransferase human)) and HYPK,
which associate with the ribosome (9–11). The human and
fruit fly Naa50p enzymes are essential for normal sister chro-
matid cohesion and chromosome condensation, but the NatA
complex was not implicated in this phenotype, suggesting that
this is attributed solely byNaa50p-mediatedNATactivity inde-
pendent of the complex (12–14). However, the responsible sub-
strate potentially requiring N-terminal acetylation for proper
functioning remains to be identified. Interestingly, NatA sub-
units have been shown to be overexpressed in a number of
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between Lys29 and Gln15 of Naa10p and Asp532 and Gln491 of 
Naa15p. Single point mutations in this region did not break up the 
complex and had only modest effects on substrate binding and cataly-
sis (Table 2), probably owing to the extensiveness of the interface. 
A smaller hydrophobic interface is formed between Naa10p His20 
and Naa15p Phe449 and Trp494 and is supplemented with a hydro-
gen bond between Naa10p Gln25 and Naa15p Arg448. This region 
of Naa15p directly stabilizes the position of the Naa10p A1 helix as 
well as the Naa10p A1–A2 loop and as a result is crucial for proper 
complex formation. This is evident from the observation that alanine 
point mutations at either Naa15p Arg448 or Naa15p Phe449 were 
able to disrupt NatA complex formation. Several additional scattered 
intermolecular interactions serve to supplement the Naa10p-Naa15p 
interface (Supplementary Fig. 3).
Molecular basis for Naa15p modulation of Naa10p acetylation
To explore the molecular basis for Naa15p modulation of Naa10p 
acetyltransferase activity, we determined the X-ray crystal structure of 
Naa10p of S. pombe in the absence of Naa15p, for comparison with the 
holo-NatA complex (Table 1). We determined the structure of Naa10p 
(residues 1–156) to 2.00-Å resolution, using a combination of single- 
wavelength anomalous diffraction and molecular replacement (model, 
NAA50) to phase data collected on a selenomethionine-derivatized 
Naa10p protein. An alignment of the complexed and uncomplexed 
forms of Naa10p revealed that the A1–loop–A2 segment assumes 
a substantially different conformation in the presence of Naa15p 
(Fig. 2a). Notably, this conformational change is driven by the move-
ment of several hydrophobic residues in Naa10p A2 (Leu28, Leu32 
and Ile36), which make intramolecular interactions with residues in 
Naa10p A1 and B3 (Ile8, Leu11, Met14, Tyr55 and Tyr57) in apo-
Naa10p but shift to make alternative intermolecular interactions 
with helices of Naa15p in the NatA complex (Figs. 1c and 2b). As 
a result of this interaction, the C-terminal region of the A1 helix 
undergoes an additional helical turn, which helps to reposition the 
A1–A2 loop. Notably, docking of the apo-Naa10p structure into the 
corresponding binding pocket of Naa15p showed a clash between the 
Naa10p A1–loop–A2 and Naa15p Arg448 and Naa15p Phe449 of A25 
(Fig. 2c)—the same interface that we have shown to be necessary for 
proper complex formation (Fig. 1d and Table 2).
As a result of the Naa15p interaction along one side of the Naa10p 
A1–loop–A2 region, residues on the opposite side of this loop region 
appear to adopt a specific conformation that is essential for catalysis 
of traditional substrates (alanine, cysteine, glycine, serine, threonine 
or valine) (Supplementary Videos 2 and 3). Specifically, Naa10p 
residues Leu22 and Tyr26 shift about 5.0 Å from surface-exposed 
positions to buried positions in the active site, and Naa10p Glu24 
moves by about 4.0 Å, substantially altering the landscape of the NatA 
active site (Fig. 2d). All of these residues are well ordered in both 
structures (Supplementary Fig. 4). Our comparison of the com-
plexed and uncomplexed structures suggests that the auxiliary subunit 
induces an allosteric change in the Naa10p active site to an extent that 
is required for the mechanism of catalysis by the NatA complex, and 
Naa10p is likely to represent an active GNAT fold. Consistent with 
this hypothesis, a backbone alignment of key active site elements in 
active Naa10p with the corresponding region in the independently 
active human NAA50 that selects a 1-Met-Leu-2 N-terminal sequence 
shows a high degree of structural conservation (r.m.s. deviation of 
1.52 Å). The corresponding alignment of the complexed and uncom-
plexed forms of Naa10p showed less structural conservation, with an 
r.m.s. deviation of 2.43 Å (Fig. 2e).
Substrate peptide binding and NatA inhibition
To determine the molecular basis for substrate-specific peptide bind-
ing by NatA, and in particular how, unlike most other NATs, it is able 
to accommodate a number of nonmethionine N-terminal substrates, 
we synthesized a bisubstrate conjugate in which CoA is covalently 
linked to a biologically relevant substrate peptide fragment with the 
sequence 1-SASEA-5 (CoA-SASEA). We performed inhibition stud-
ies with CoA-SASEA and with a control compound, acetonyl CoA, 
which is a nonhydrolyzable acetyl CoA analog (Fig. 3a). Half-maxi-
mum inhibitory concentration (IC50) determinations revealed that 
CoA-SASEA had an IC50 of 1.4 o 1.0 MM, whereas acetonyl CoA 
had an IC50 of 380 o 10 MM (Fig. 3b). To assess the specificity of this 
inhibitor toward NatA, we also calculated IC50 values of CoA-SASEA 
and acetonyl CoA with NAA50, a NAT that requires a substrate 
N-terminal methionine residue. We found that CoA-SASEA has an 
IC50 of 11 o 2 MM, whereas acetonyl CoA has an IC50 of 130 o 12 MM 
(Fig. 3b). With NAA50, the addition of a SASEA peptide portion 
was able to increase the potency of acetonyl CoA by only about ten-
fold, whereas with NatA this peptide addition exhibited an increase 
in potency of about 300-fold. The greater potency of acetonyl CoA 
with NAA50 over Naa10p can be explained by the stronger binding of 
acetyl CoA to NAA50 (Km = 27 o 2 MM) than to Naa10p (Km = 59 o 
5 MM). The markedly higher potency of the CoA-SASEA inhibitor 
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Figure 1 Overall structure of the NatA complex bound to acetyl CoA. (a) Naa10p (teal) and Naa15p (brown) subunits, shown in cartoon, bound to 
acetyl CoA (CPK coloring and stick format). Only Naa15p helices that contact Naa10p are labeled. The dashed brown line represents a disordered 
loop region in Naa15p. The dimensions of the complex are 107 Å × 85 Å × 70 Å. (b) A 90° rotation of the view in a. Helices that are depicted in c and 
d are labeled. (c) Zoom view highlighting key residues that compose the predominantly hydrophobic interface between Naa10p A1–A2 and Naa15p 
A29–A30. (d) Zoom view of the intersubunit interface at the C-terminal region of Naa10p A1 and the Naa15p A25–A27–A28 helices.
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The cotranslational process of N-terminal acetylation occurs on ~85% 
of human proteins and ~50% of yeast proteins and mediates a wide 
range of biological processes including cellular apoptosis, enzyme 
regulation, protein localization and the N-end rule for protein degra-
dation1–6. At least three NAT complexes that perform this modifica-
tion, NatA, NatB and NatC, exist as heterodimers with one unique 
catalytic subunit and an additional unique auxiliary subunit that both 
activates the enzymatic component and anchors the complex to the 
ribosome during translation7–13. Aberrant expression of the proteins 
that make up t e atA complex has been observed in a number of 
cance -cell tissues; c nsequent , AT enzymes are emerging targets 
for chemotherapeutic development14–21.
The three NAT complexes are highly conserved in eukaryotes 
from yeast to humans and are differentiated from one another on the 
basis of their substrate specificities1,5,22–24. NatA, which is composed 
of the catalytic NAA10 subu it and the auxiliary NAA15 subunit, is 
the most promiscuous of all NAT enzymes; classically, it acetylates an 
A-amino group on nascent peptide chains with an N-terminal alanine, 
cysteine, glycine, serine, threonine or valine residue1,22,24,25. Notably, 
recent studies demonstrate that NAA10 also exists as a monomer 
in cells and that it can acetylate the A-amino group of substrates 
with N-terminal aspartate and glutamate residues that can be gen-
erated post-translationally, but it will not acetylate traditional 
NatA substrates26. The NatB and NatC complexes acetylate the 
N termini of proteins with an N-terminal methionine with further 
specificity dependent upon the identity of the second residue13,23,25,27. 
Although NATs as well as many other lysine side chain acetyl-
transferases require binding partners for optimal catalytic activity, 
no acetyltransferase has been structurally characterized in the 
presence of its activating partner28–30.
Three additional NAT enzymes, NatD–NatF, have been identified 
and appear to be independently active. They also have a more limited 
set of biologically relevant substrates and are not well characterized 
across eukaryotes31–35. Currently, there is no structure of a NAT 
complex or any of the integral subunits, and the mechanism of sub-
strate-specific catalytic regulation by the auxiliary subunits remains 
uncharacterized. The only eukaryotic NAT for which structural data 
is av ilable is the human NatE (NAA50) enzyme, which is independ-
ently active an  has only o e known biologically elevant substrate; 
this substrate, containing a 1-MLGP-4 N-t rminal sequence, was 
present in an X-ray crystal structure1,36.
In this study we set out to determine the molecular basis for sub-
strate binding, acetylation specificity and mode of catalysis of the 
N tA complex and to determine the role of the auxiliary subunit in 
these activities. Toward this goal, we determined the X-ray crystal 
structures of the holo-NatA complex bound to acetyl CoA and a 
bisubstrate inhibitor, determined the structure of the Naa10p sub-
unit bound to acetyl CoA in its uncomplexed form that preferentially 
acetylates a unique subset of substrates, and carried out structure-
guided mutational analysis to derive structure-function correlations 
underlying NatA acetylation.
RESULTS
Overall structure of NatA
In an attempt to prepare the NatA complex for X-ray 
structure determination, we overexpressed the human complex 
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Molecular basis for N-terminal acetylation by the 
heterodimeric NatA complex
Glen Liszczak1,2, Jacob M Goldberg2, Håvard Foyn3, E James Petersson2, Thomas Arnesen3,4 &  
Ronen Marmorstein1,2
N-terminal acetylation is ubiquitous among eukaryotic proteins and controls a myriad of biological processes. Of the N-terminal 
acetyltransferases (NATs) that facilitate this cotranslational modification, the heterodimeric NatA complex has the most diversity 
for substrate selection and modifies the majority of all N-terminally acetylated proteins. Here, we report the X-ray crystal 
structure of the 100-kDa holo-NatA complex from Schizosaccharomyces pombe, in the absence and presence of a bisubstrate 
peptide-CoA–conjugate inhibitor, as well as the structure of the uncomplexed Naa10p catalytic subunit. The NatA-Naa15p 
auxiliary subunit contains 13 tetratricopeptide motifs and adopts a ring-like topology that wraps around the NatA-Naa10p 
subunit, an interaction that alters the Naa10p active site for substrate-specific acetylation. These studies have implications  
for understanding the mechanistic details of other NAT complexes and how regulatory subunits modulate the activity of the 
broader family of protein acetyltransferases.
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The cotranslational process of N-terminal acetylation occurs on ~85% 
of human proteins and ~50% of yeast proteins and mediates a wide 
range of biological processes including cellular apoptosis, enzyme 
regulation, protein localization and the N-end rule for protein degra-
dation1–6. At least three NAT complexes that perform this modifica-
tion, NatA, NatB and NatC, exist as heterodimers with one unique 
catalytic subunit and an additional unique auxiliary subunit that both 
activates the enzymatic component and anchors the complex to the 
ribosome during translation7–13. Aberrant expression of the proteins 
that make up the NatA complex has been observed in a number of 
cancer-cell tissues; consequently, NAT enzymes are emerging targets 
for chemotherapeutic development14–21.
The three NAT complexes are highly conserved in eukaryotes 
from yeast to humans and are differentiated from one another on the 
basis of their substrate specificities1,5,22–24. NatA, which is composed 
of the catalytic NAA10 subunit and the auxiliary NAA15 subunit, is 
the most promiscuous of all NAT enzymes; classically, it acetylates an 
A-amino group on nascent peptide chains with an N-terminal alanine, 
cysteine, glycine, serine, threonine or valine residue1,22,24,25. Notably, 
recent studies demonstrate that NAA10 also exists as a monomer 
in cells and that it can acetylate the A-amino group of substrates 
with N-terminal aspartate and glutamate residues that can be gen-
erated post-translationally, but it will not acetylate traditional 
NatA substrates26. The NatB and NatC complexes acetylate the 
N termini of proteins with an N-terminal methionine with further 
specificity dependent upon the identity of the second residue13,23,25,27. 
Although NATs as well as many other lysine side chain acetyl-
transferases require binding partners for optimal catalytic activity, 
no acetyltransferase has been structurally characterized in the 
presence of its activating partner28–30.
Three additional NAT enzymes, NatD–NatF, have been identified 
and appear to be independently active. They also have a more limited 
set of biologically relevant substrates and are not well characterized 
across eukaryotes31–35. Currently, there is no structure of a NAT 
complex or any of the integral subunits, and the mechanism of sub-
strate-specific catalytic regulation by the auxiliary subunits remains 
uncharacterized. The only eukaryotic NAT for which structural data 
is available is the human NatE (NAA50) enzyme, which is independ-
ently active and has only one known biologically relevant substrate; 
this substrate, containing a 1-MLGP-4 N-terminal sequence, was 
present in an X-ray crystal structure1,36.
In this study we set out to determine the molecular basis for sub-
strate binding, acetylation specificity and mode of catalysis of the 
NatA complex and to determine the role of the auxiliary subunit in 
these activities. Toward this goal, we determined the X-ray crystal 
structures of the holo-NatA complex bound to acetyl CoA and a 
bisubstrate inhibitor, determined the structure of the Naa10p sub-
unit bound to acetyl CoA in its uncomplexed form that preferentially 
acetylates a unique subset of substrates, and carried out structure-
guided mutational analysis to derive structure-function correlations 
underlying NatA acetylation.
RESULTS
Overall structure of NatA
In an attempt to prepare the NatA complex for X-ray 
structure determination, we overexpressed the human complex 
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Molecular basis for N-terminal acetylation by the 
heterodimeric NatA complex
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N-terminal acetylation is ubiquitous among eukaryotic proteins and controls a myriad of biological processes. Of the N-terminal 
acetyltransferases (NATs) that facilitate this cotranslational modification, the heterodimeric NatA complex has the most diversity 
for substrate selection and modifies the majority of all N-terminally acetylated proteins. Here, we report the X-ray crystal 
structure of the 100-kDa holo-NatA complex from Schizosaccharomyces pombe, in the absence and presence of a bisubstrate 
peptide-CoA–conjugate inhibitor, as well as the structure of the uncomplexed Naa10p catalytic subunit. The NatA-Naa15p 
auxiliary subunit contains 13 tetratricopeptide motifs and adopts a ring-like topology that wraps around the NatA-Naa10p 
subunit, an interaction that alters the Naa10p active site for substrate-specific acetylation. These studies have implications  
for understanding the mechanistic details of other NAT complexes and how regulatory subunits modulate the activity of the 
broader family of protein acetyltransferases.
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materials/methods	IP	mass	spec
5 x 106 HEK293 cells were seeded in 10 cm dish and transfected after 24 h with 
pcDNA3.1 V5/His hNaa10 wt, pcDNA3.1 V5/His hNaa10 S37P or corresponding 
empty vector. Cells were lysed after 48 h in 500 µl lysis buffer (0.2 % Triton X-
100, 0.1 % DTT and 1 x Complete protease inhibitor cocktail in PBS) per dish and 
cellular debris was pelleted at 20,800 g for 10 min. The lysates were pooled and 
protein concentration was determined using APA protein assay (Cytoskeleton). 
For IP, 40 mg total protein were incubated with 400 µl anti-V5-coupled magnetic 
beads (Invitrogen) for 2 h at 4°C under constant agitation. Beads were washed 3 
times with lysis buffer, 1 x with PBS and once with 50 % PBS. Proteins were 
digested with trypsin off the beads and labelled with distinct isobaric 
iTRAQ reagents. The samples were combined and subjected to standard 2D 
MudPIT LCMS and analyzed using a Thermo Velos Orbitrap mass spectrometer. 
Peptides were fragmented using the high-energy collision (HCD) cell to avoid low-
mass ejection of iTRAQ reporter ions. The effects of compression of iTRAQ ratio 
values were procedurally minimized by using narrow precursor selection 
tolerances (1.2Da) and optimized settings for HCD collision energy and 
transmission efficiency. iTRAQ labeled peptides remain isobaric in MS but 
following HCD the iTRAQ reporter ions appear as distinct ions in the range 113 to 
121 m/z in each MS/MS spectrum. The relative abundance of the peptides (and 
thus corresponding proteins) were deduced directly from the relative intensities of 
the corresponding reporter ions. Peak lists were extracted from instrument raw 
data files using the MASCOT Distiller software (MatrixScience) and the MASCOT 
searches were performed on a 64-processor cluster (Perkins et al. 1999). False 
discovery rates (FDR) were estimated by searching equivalent reversed or 
randomized sequence databases, typically using a cutoff value of 1% FDR. 
Protein-abundance ratios were calculated using intensity weighted averages from 
matching peptides after outlier removal. The relative enrichment in the samples 
were calculated as a ratio of the intensities between the samples and the 
empty-vector control. The whole experiment was done twice.
slides	IP	&	mass	spec
wt S37P
1 RPLP1* 60S acidic ribosomal protein P1 30.3 23.7
2 RPS25* 40S ribosomal protein S25 29.4 18.1
3 NACA Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Fragment) 27.5 11.0
4 HYPK Huntingtin-interacting protein K 27.0 4.3
5 RPL38* 60S ribosomal protein L38 26.8 18.3
6 RPL8* 60S ribosomal protein L8 24.7 14.4
7 RPS13* 40S ribosomal protein S13 24.1 13.5
8 RPS28* 40S ribosomal protein S28 23.8 14.6
9 FAU* 40S ribosomal protein S30 23.7 15.9
10 RPL27A* 60S ribosomal protein L27a 21.9 11.9
11 RPL6* 60S ribosomal protein L6 21.8 13.7
12 CAPRIN1 Caprin-1 21.7 12.4
13 GPATCH4 G patch domain-containing protein 4 21.4 15.3
14 NAA15 N-alpha-acetyltransferase 15, NatA auxiliary subunit 21.2 5.2
15 RPS18* 40S ribosomal protein S18 20.9 12.0
16 RPS14* 40S ribosomal protein S14 20.7 11.6
17 RPS19* 40S ribosomal protein S19 20.3 12.8
18 RPL13* 60S ribosomal protein L13 19.9 11.5
19 NDNL2 Melanoma-associated antigen G1 19.6 4.7
20 RPS16* 40S ribosomal protein S16 19.5 13.6
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Interplay between trigger factor and other protein
biogenesis factors on the ribosome
Thomas Bornemann1, Wolf Holtkamp1 & Wolfgang Wintermeyer1
Nascent proteins emerging from translating ribosomes in bacteria are screened by a number
of ribosome-associated protein biogenesis factors, among them the chaperone trigger factor
(TF), the signal recognition particle (SRP) that targets ribosomes synthesizing membrane
proteins to the membrane and the modifying enzymes, peptide deformylase (PDF) and
methionine aminopeptidase (MAP). Here, we examine the interplay between these factors
both kinetically and at equilibrium. TF rapidly scans the ribosomes until it is stabilized on
ribosomes presenting TF-specific nascent chains. SRP binding to those complexes is strongly
impaired. Thus, TF in effect prevents SRP binding to the majority of ribosomes, except those
presenting SRP-specific signal sequences, explaining how the small amount of SRP in the cell
can be effective in membrane targeting. PDF and MAP do not interfere with TF or SRP binding
to translating ribosomes, indicating that nascent-chain processing can take place before or in
parallel with TF or SRP binding.
DOI: 10.1038/ncomms5180
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During protein biosynthesis, the nascent peptide chains ontranslating ribosomes are scanned by a number of proteinligands, called ribosome-associated protein biogenesis
factors (RPBs), such as the chaperone trigger factor (TF), the
signal recognition particle (SRP) and the processing enzymes
peptide deformylase (PDF) and methionine aminopeptidase
(MAP). RPBs bind to the ribosome close to the exit of the
emerging nascent peptide by attaching to a confined binding
platform comprising six ribosomal proteins surrounding the
polypeptide tunnel exit (Fig. 1). Whether co-translational binding
of these ligands is regulated and to which extent RPBs can bind
simultaneously or compete for binding is not clear1.
TF is an early-acting ribosome-associated chaperone that binds
nascent proteins emerging from the ribosome and prevents co-
translational misfolding of these proteins2–4. TF is present in the
cell in excess over ribosomes and potentially interacts with many
nascent proteins4,5, with a preference for hydrophobic stretches
flanked by positively charged amino acids6. Structural and
mechanistic aspects of TF function have been reviewed
recently4,7,8. SRP initiates the targeting of ribosome nascent-
chain complexes (RNCs) that are synthesizing membrane
proteins to the protein-conducting channel (translocon) in the
plasma membrane9–11. SRP scans translating ribosomes for
emerging hydrophobic signal-anchor sequences (SAS). Binding
to an SAS switches SRP to the targeting mode and initiates co-
translational membrane targeting by binding to the SRP receptor
and transfer to the translocon12,13. SRP and TF together can bind
to the ribosome, although both contact protein L23 at the peptide
exit (Fig. 1)3,14–18; changes in crosslinking patterns indicate that
conformational changes accompany the accommodation of the
two ligands on one ribosome19,20.
Depending on the functional state of the ribosome, the
interaction of SRP with ribosomes takes place in different time
domains. In the ‘scanning’ mode, SRP binds to non-translating
ribosomes or ribosomes that do not synthesize membrane
proteins in a readily reversible fashion13, with effective
dissociation rates in the range of 10 s! 1, allowing other RPBs
to bind in a stochastic fashion. However, the extent to which
RPBs can enter when SRP is stabilized on translating ribosomes
with short nascent chains (‘stand-by’; effective off-rate about
1 s! 1) or on ribosomes synthesizing membrane proteins
(‘targeting’; effective off-rate about 0.1 s! 1)12,13 is not clear.
The interplay of TF with other RPBs on the ribosome is not clear
as well, as it has been reported that TF binds to and dissociates
from ribosomes very slowly21–23, such that stably bound TF
might interfere with the binding of other RPBs.
Protein synthesis in bacteria starts with the incorporation of
formylated methionine. Deformylation by PDF and removal of
the N-terminal methionine by MAP are essential for the stability
and function of many proteins1. The C-terminal helix of PDF has
been located on the ribosome at protein L22 close to the peptide
exit, suggesting how PDF might bind24. Current models argue
that this location of PDF allows for early scanning and
deformylation of nascent chains when they just appear outside
the ribosomal exit tunnel. Deformylation and methionine
removal occur on 60–80% of all proteins and control the
stability of proteins, as the N-terminal amino acid determines the
susceptibility of many mature proteins for the cellular protein
degradation machinery25,26. It has been proposed that PDF and
TF act in a concerted fashion3, whereas recent data from selective
ribosome profiling indicated that TF and PDF do compete for
ribosome binding in vivo27. Conversely, on the basis of binding
data obtained in vitro, it was suggested that TF and SRP did not
compete with PDF for binding to ribosomes or RNCs28. Although
MAP binds to the ribosome at the peptide exit close to proteins
L17 and L23, it does not compete with TF or SRP, but strongly
competes with PDF28.
To obtain quantitative data on the interplay of RPBs, including
TF, SRP, PDF and MAP, at the peptide exit of the ribosome, we
monitor fluorescence resonance energy transfer (FRET) between
fluorophore-labelled ribosomes or RNCs and labelled TF or SRP.
To relate competition binding data to the stability of the complexes,
we measure the interaction of TF with non-translating ribosomes
as well as with RNCs, including the kinetics of complex formation
and dissociation. We observe that TF rapidly binds to, and
dissociates from vacant or translating ribosomes, unless nascent
chains comprising TF-specific binding sites are presented, which
strongly stabilize the complex. The competition between TF and
SRP and other RPBs for binding to the ribosome is examined at
equilibrium providing quantitative data that reveal the choreo-
graphy of RPBs at the ribosomal peptide exit. The data reveal that
simultaneous binding of TF and SRP to one ribosome lowers the
binding affinity about 10-fold. Thus, in effect, TF precludes SRP
binding to TF-specific RNCs. In contrast, the binding of PDF or
MAP to RNCs does not influence the binding of TF or SRP.
Results
Kinetics of TF interaction with non-translating ribosomes. To
determine the kinetics of TF–ribosome complexes, we monitored
TF binding to, and dissociation from, ribosomes by FRET between
ribosomes labelled with 7-Diethylamino-3-((((2-Maleimidyl)
ethyl)amino)carbonyl)coumarin (MDCC; donor) at position 21
of protein L23 (ref. 13) and TF labelled with Bodipy-FL (Bpy;
acceptor) at position 99. To examine the kinetics of ribosome–TF
complex formation, we rapidly mixed MDCC-labelled ribosomes
with TF(Bpy) and monitored the increase of the acceptor signal
(Fig. 2a). The signal change was single exponential, and long-time
measurements did not reveal any additional slow step
(Supplementary Fig. 1a). To verify that the signal change
observed on binding of labelled TF to ribosomes was due to
FRET, we performed a control experiment with ribosomes con-
taining cysteine-free wild-type L23, which had been reacted with
MDCC, leading to low-level incorporation of MDCC at proteins
other than L23. Essentially, no signal change was observed with
those ribosomes (Supplementary Fig. 1b), confirming that the
signal changes observed with L23-labelled ribosomes were due to
L29
L23
Exit
L22
L32
PDF
L17
MAP
SRP, TF
L24
Figure 1 | Binding platform for RPBs at the peptide exit of the bacterial
50S ribosomal subunit. Ribosomal proteins at or near the peptide exit of
the 50S subunit (grey outline) are indicated along with the RPBs binding to
protein L23 (SRP, TF), L22 (PDF) or L17 (MAP) (for references, see text).
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RNCs, as indicated by the loss of FRET with increasing
concentrations of PDF.
Small effect of MAP on ribosome binding of TF and SRP. It is
not known to which extent the binding of MAP, which may enter
RNCs early during protein synthesis, influences the binding of TF
or SRP. On addition of MAP in saturating concentrations, Kd
values for TF or SRP increased less than twofold for the com-
plexes with non-translating ribosomes or the respective RNCs
(Supplementary Fig. 5). Fluorescence amplitude changes were
small as well. These results indicate that MAP bound to ribo-
somes, as reported recently28, and did not displace TF or SRP
from non-translating ribosomes or RNCs or change affinities.
Discussion
One major finding of this paper is that TF rapidly forms transient
complexes with ribosomes. The kinetic stability of the complexes
depends on the functional state of the ribosomes and the nature
of the nascent peptide presented on the ribosome. Ribosome–TF
complexes form with second-order rate constants of
100–200mM! 1 s! 1, that is, complex formation is close to
diffusion controlled. The complexes are short-lived, with half-
life times of 60ms, when the ribosomes are vacant or present a
nascent protein lacking a TF-binding motif, such as in Lep75-
RNC; in these cases binding affinities are in the range of 0.1–
0.2 mM. The ribosome–TF complexes are strongly stabilized (20–
30-fold) and binding affinities are high (Kd values of 2–10 nM)
when RNCs expose nascent peptides encompassing TF-binding
sequences, such as in the proOmpA75- or HemK75-RNCs used
here. Up to about 20-fold higher Kd values of TF binding to
vacant ribosomes or various RNCs, including RNCs presenting
the nascent beta subunit of RNA polymerase, a TF substrate,
were reported previously31. However, those values were obtained
by pelleting ribosome–TF complexes, which apparently
underestimated affinities, in particular when the complexes
were unstable kinetically, such as the complexes with vacant
ribosomes or Lep-RNCs. The present parameters of TF–ribosome
interaction also differ from published values determined using
fluorescence-labelled TF21–23. In that work, half-life times around
10 s and equilibrium dissociation constants of 1–2 mM were
observed for the complexes of labelled TF with non-translating
ribosomes and half-life times up to 50 s for translating ribosomes
exposing TF-binding nascent chains21–23. However, as we show
here, the slow kinetics of complex formation and dissociation as
well as low-affinity binding observed in those experiments were
caused by the particular fluorescence label, BADAN at position
14, in TF that strongly influenced the properties of TF.
A transient character of ribosome–TF complexes resolves the
potential problem of slowly forming and long-lived TF complexes
with translating ribosomes, including non-substrate RNCs, which
might interfere with nascent-chain processing by PDF and MAP
and/or membrane targeting by SRP, despite concurrent binding.
Thus, rather than staying bound on translating ribosomes and
‘waiting’ for nascent peptides to emerge from the exit tunnel, as
suggested by the previously reported slow kinetics, the interaction
of TF with ribosomes appears highly dynamic. An off-rate of
about 12 s! 1 matches a translation rate of 10 s! 1 and, combined
with a high effective on-rate (E1,000 s! 1, based on an
approximate second-order association rate constant of
E100mM! 1 s! 1 and assuming E10 mM free TF monomer in
the monomer–dimer equilibrium32) allows TF to inspect many
translating ribosomes at appropriate speed and settle on
TF-specific sequences as soon as they emerge from the exit
tunnel. This may be important for the chaperone function of TF
in preventing premature, potentially erroneous folding of nascent
proteins.
Previous kinetic analyses revealed that, similar to what we
report here for TF, SRP scans ribosomes rapidly until binding is
stabilized on translating ribosomes that have their peptide exit
tunnel filled (‘stand-by’) or expose a signal-anchor sequence
(‘targeting’)13. Assuming an SRP concentration in vivo of 0.1 mM
and diffusion-controlled binding, as observed in vitro13, the
effective rate of SRP binding to ribosomes or RNCs is about
10 s! 1. This rate matches the rate of TF dissociation from non-
TF-substrate RNCs, Lep75-RNC in our experiments, which may
optimize the access of SRP to its substrate RNCs. The observed
destabilization of SRP binding to non-substrate RNCs by high-
affinity TF binding to TF-substrate RNCs enhances the
specificity, in particular of SRP, for binding to its substrate
RNCs (Fig. 6). Although SRP and TF can bind to ribosomes
concurrently, the destabilization has the consequence that SRP is
practically excluded from the large number of RNCs to which TF
is bound strongly5. Rather, SRP will predominantly be bound to
RNCs with short nascent peptides filling the exit tunnel and, in
particular, RNCs presenting an SAS, as SRP binds to those RNCs
with an apparent KdE20 nM even at saturation with TF, which is
well below the intracellular concentration of SRP of around
100 nM. Thus, the partial competitive binding behaviour of TF
and SRP in effect increases the specificity of the small amount of
SRP-specific
RNCs
Membrane
targetting
12 s–1
0.5 s–1
TF-specific
RNCs
Downstream
chaperones
15 s–1
0.1 s–1
SRPTF
Figure 6 | Interplay of TF and SRP on translating ribosomes. Concurrent
binding of TF or SRP to RNCs presenting the respective specific nascent
chain (SRP-specific SAS, red; TF-specific sequence, blue) leads to
weakening of the binding of the respective other ligand (values of Kd
increased eightfold or 415-fold, respectively (Fig. 3)), as indicated by red
lines. Because SRP dissociates from RNCs in three steps, average values of
koff calculated from the three rate constants k! 1, k! 2 and k! 3 are given13.
Values of koff for TF dissociation from RNCs are taken from Table 1. Second-
order rate constants for TF or SRP binding to RNCs ranged from about 100
to 200mM! 1 s! 1 (Table 1 and ref. 13), indicating near diffusion-controlled
binding.
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